Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MORN repeat-containing protein 1 (MORN1) is a protein encoded by the human *MORN1* gene, located on chromosome 1p36.33[2]. It contains multiple MORN (Membrane Occupation and Recognition Nexus) repeats—a motif present in a variety of proteins thought to mediate membrane association or protein-protein interactions[1][2][3]. In humans, the protein is 497 amino acids long and has seven MORN repeats[2]. MORN1 is predicted to be cytoplasmic, nuclear, or mitochondrial but is not a transmembrane protein[2]. MORN1 orthologs are found across eukaryotes and even bacteria. In the parasite *Toxoplasma gondii*, MORN1 is essential for nuclear division, daughter cell budding, and is associated with cytoskeletal structures during cell division[2][5]. Its molecular function is not fully understood in humans, but evidence from parasitic organisms suggests a key role in cytoskeletal organization and possibly membrane interactions[1][2]. Dimerization and oligomerization via MORN repeats appear to be structural features, and MORN1 may mediate interactions between the cytoskeleton and membranes[1][3][5]. There is currently no evidence that MORN1 is a therapeutic target, receptor, or direct drug target in humans. No drugs are known to interact with MORN1 and there are no established roles in human disease, nor are there safety concerns, mechanism of action, or biomarker data reported for this protein in clinical contexts[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MORN repeat-containing protein 1 (MORN1).